MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of investments
$167,878K
Proceeds from exercise of
stock options
$623K
Net cash provided by
(used in) investing...
$42,244K
Net cash provided by
financing activities
$616K
Canceled cashflow
$125,634K
Canceled cashflow
$7K
Net increase
(decrease) in cash, cash...
$917K
Canceled cashflow
$41,943K
Purchases of investments
$125,618K
Purchases of property and
equipment
$16K
Stock-based compensation
expense
$4,739K
Accrued expenses and
other current...
$1,687K
Prepaid expenses and
other current assets
-$670K
Other non-current
assets
-$618K
Non-cash lease expense
$86K
Depreciation on property and
equipment
$24K
Repurchase of common stock
originally issued upon...
$7K
Net cash used in
operating activities
-$41,943K
Canceled cashflow
$7,824K
Net loss
-$46,062K
Accretion of discount on
investments
$2,997K
Accounts payable
-$609K
Operating lease
liabilities
-$99K
Back
Back
Cash Flow
source: myfinsight.com
Tourmaline Bio, Inc. (TRML)
Tourmaline Bio, Inc. (TRML)